PHARMACY

Alembic gets FDA OK for generic Vesicare

BY Sandra Levy

Alembic has received the Food and Drug Administration’s approval for solifenacin succinate tablets, in 5-mg and 10-mg dosage strengths.

The product is indicated for the treatment of overactive bladder.

It is the generic of Astellas Pharma’s Vesicare tablets.

Solifenacin succinate tablets 5 mg and 10 mg had a market value of approximately $967 million for the 12 months ending December 2018, according to IQVIA.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer